Published in J Immunol on December 01, 1998
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci U S A (2003) 5.49
LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems. J Clin Invest (2007) 2.57
Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J Clin Invest (2000) 1.98
Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy. Clin Microbiol Rev (2004) 1.95
Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4(+) T cell responses. Proc Natl Acad Sci U S A (1999) 1.70
Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells. Proc Natl Acad Sci U S A (2000) 1.31
Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity. J Virol (2006) 1.25
Differential expression of CTLA-4 among T cell subsets. Clin Exp Immunol (2004) 1.15
Anergy in peripheral memory CD4(+) T cells induced by low avidity engagement of T cell receptor. J Exp Med (2001) 1.00
Impaired activation-induced cell death promotes spontaneous arthritis in antigen (cartilage proteoglycan)-specific T cell receptor-transgenic mice. Arthritis Rheum (2010) 0.84
Late administration of murine CTLA-4 blockade prolongs CD8-mediated anti-tumor effects following stimulatory cancer immunotherapy. Cancer Immunol Immunother (2015) 0.79
T cell receptor (TCR) signal strength controls arthritis severity in proteoglycan-specific TCR transgenic mice. Clin Exp Immunol (2012) 0.79
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol (1997) 5.95
A functional dichotomy in CD4+ T lymphocytes. Immunol Today (1988) 4.18
Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J Exp Med (1995) 3.98
Signals and signs for lymphocyte responses. Cell (1994) 3.66
Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem (1997) 3.66
Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer (1998) 3.55
Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med (1997) 3.33
Nipping early risk factors in the bud: preventing substance abuse, delinquency, and violence in adolescence through interventions targeted at young children (0-8 years). Prev Sci (2001) 2.85
Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med (1995) 2.80
Identification and high-density mapping of gene-rich regions in chromosome group 1 of wheat. Genetics (1996) 2.66
Cloned, Ia-restricted T cells that do not produce interleukin 4(IL 4)/B cell stimulatory factor 1(BSF-1) fail to help antigen-specific B cells. J Immunol (1987) 2.53
Distinct functional phenotypes of cloned Ia-restricted helper T cells. J Exp Med (1985) 2.39
Derivatives of 6-aminopenicillanic acid. XI. Alpha-amino-p-hydroxybenzylpenicillin. J Chem Soc Perkin 1 (1971) 2.39
Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages. J Immunol (1989) 2.32
B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J Immunol (1995) 2.29
Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation. J Immunol (1989) 2.24
Late dominance of the inflammatory process in murine influenza by gamma/delta + T cells. J Exp Med (1990) 2.21
The relationship of IL-4- and IFN gamma-producing T cells studied by lineage ablation of IL-4-producing cells. Cell (1993) 2.19
Autocrine growth of CD4+ T cells. Differential effects of IL-1 on helper and inflammatory T cells. J Immunol (1988) 2.12
Salicylates, nitric oxide, malaria, and Reye's syndrome. Lancet (2001) 2.08
CD4+ T cells: specificity and function. Immunol Rev (1988) 2.04
IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. J Immunol (1998) 1.92
Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells. J Immunol (1997) 1.90
Anti-idiotype induced regulation of helper cell function for the response to phosphorylcholine in adult BALB/c mice. J Exp Med (1978) 1.89
Mice whose B cells cannot produce the T15 idiotype also lack an antigen-specific helper T cell required for T15 expression. J Exp Med (1979) 1.86
Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum (1996) 1.85
T helper 1 cells and interferon gamma regulate allergic airway inflammation and mucus production. J Exp Med (1999) 1.85
Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo. J Immunol (1993) 1.82
Differences in the expression profiles of CD45RB, Pgp-1, and 3G11 membrane antigens and in the patterns of lymphokine secretion by splenic CD4+ T cells from young and aged mice. J Immunol (1990) 1.79
Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4. J Clin Invest (2000) 1.76
Blood-brain barrier function in cerebral malaria in Malawian children. Am J Trop Med Hyg (2001) 1.74
Selective activation of Th1- and Th2-like cells in vivo--response to human collagen IV. Immunol Rev (1991) 1.72
Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils. J Immunol (1999) 1.70
Malaria infection during pregnancy: intrauterine growth retardation and preterm delivery in Malawi. J Infect Dis (1999) 1.68
Who is the patient? A family case study of a recurrent dilemma in family practice. J Fam Pract (1983) 1.63
Absence of an antigen-specific helper T cell required for the expression of the T 15 idiotype in mice treated with anti-mu antibody. Eur J Immunol (1980) 1.62
Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation. J Immunol (1997) 1.61
Psychosocial influences on older adults' interest in participating in bowel cancer screening. Prev Med (2000) 1.59
Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care (1998) 1.58
Differential activation of cytokine genes in normal CD4-bearing T cells is stimulus dependent. Eur J Immunol (1989) 1.57
Characterization of a Brucella sp. strain as a marine-mammal type despite isolation from a patient with spinal osteomyelitis in New Zealand. J Clin Microbiol (2006) 1.57
Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding. J Immunol (1997) 1.56
Cytokine expression in the brain in human cerebral malaria. J Infect Dis (1999) 1.54
Generation and functional capacity of polyclonal alloantigen-specific memory CD4 T cells. Am J Transplant (2006) 1.53
MHC control of CD4+ T cell subset activation. J Exp Med (1989) 1.45
Another cautionary note on the use of PCNA. J Pathol (1992) 1.42
Survival of naive CD4 T cells: roles of restricting versus selecting MHC class II and cytokine milieu. J Immunol (1999) 1.42
Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo. Mucosal Immunol (2009) 1.39
STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. Science (1999) 1.38
Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum (1996) 1.35
CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation. J Virol (2001) 1.35
The involvement of the intestinal microflora in the expansion of CD4+ T cells with a naive phenotype in the periphery. Dev Immunol (1992) 1.34
Genomic maps of some strains within the Mycoplasma mycoides cluster. J Bacteriol (1990) 1.34
Roles of IL-4 and IFN-gamma in stabilizing the T helper cell type 1 and 2 phenotype. J Immunol (1997) 1.33
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid (1998) 1.33
Identification of human lung and skin proteins conjugated with hexamethylene diisocyanate in vitro and in vivo. Am J Respir Crit Care Med (2000) 1.32
Peptide and protein antigens require distinct antigen-presenting cell subsets for the priming of CD4+ T cells. J Immunol (1995) 1.32
Reciprocal regulation of CD30 expression on CD4+ T cells by IL-4 and IFN-gamma. J Immunol (1997) 1.29
Distinct patterns of membrane microdomain partitioning in Th1 and th2 cells. Immunity (2001) 1.28
Heterogeneity of the memory CD4 T cell response: persisting effectors and resting memory T cells. J Immunol (2001) 1.27
Cytokines in T-cell development. Immunol Today (1991) 1.26
Declining the offer of flexible sigmoidoscopy screening for bowel cancer: a qualitative investigation of the decision-making process. Soc Sci Med (2001) 1.25
Differential T cell receptor-mediated signaling in naive and memory CD4 T cells. Eur J Immunol (1997) 1.23
Activation status of the CD4-8- gamma delta-T cells recovered from mice with influenza pneumonia. J Immunol (1991) 1.21
Sex differences in lung-cancer risk associated with cigarette smoking. Int J Cancer (1993) 1.21
Isosorbide 5-mononitrate pharmacokinetics in humans. Biopharm Drug Dispos (1982) 1.20
Identification of the alternatively spliced exons of murine CD45 (T200) required for reactivity with B220 and other T200-restricted antibodies. J Exp Med (1989) 1.20
Major histocompatibility complex (MHC) control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype. Eur J Immunol (1992) 1.19
Activation requirements for CD4+ T cells differing in CD45R expression. J Immunol (1992) 1.19
Suppression of alpha-cyano-4-hydroxycinnamic acid matrix clusters and reduction of chemical noise in MALDI-TOF mass spectrometry. Anal Chem (2004) 1.19
Involvement of gamma delta T cells in respiratory virus infections. Curr Top Microbiol Immunol (1991) 1.18
Predictors of attendance in the United Kingdom flexible sigmoidoscopy screening trial. J Med Screen (2000) 1.16
Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes. Diabetes Care (1998) 1.16
Site of antigen delivery can influence T cell priming: pulmonary environment promotes preferential Th2-type differentiation. Eur J Immunol (2000) 1.16
Functional CD4 T cell subset interplay in an intact immune system. J Immunol (1993) 1.16
Developmentally regulated fetal thymic and extrathymic T-cell receptor gamma delta gene expression. Genes Dev (1990) 1.16
The extracellular domain of CD45 controls association with the CD4-T cell receptor complex and the response to antigen-specific stimulation. J Exp Med (1996) 1.16
Molecular associations on the T cell surface correlate with immunological memory. Eur J Immunol (1990) 1.15
Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol (2001) 1.14
Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3zeta expression. Blood (2001) 1.13
Subpopulations of B cells distinguished by cell surface expression of Ia antigens. Correlation of Ia and idiotype during activation by cloned Ia-restricted T cells. J Exp Med (1983) 1.13
Isoforms of the transmembrane tyrosine phosphatase CD45 differentially affect T cell recognition. Immunity (1994) 1.12
Fetal weight/placental weight ratio and perinatal outcome. Am J Obstet Gynecol (1984) 1.11
An open study to compare the pharmacokinetics, safety and tolerability of a multiple-dose regimen of azithromycin in young and elderly volunteers. Eur J Clin Microbiol Infect Dis (1991) 1.11
Ly 9, an alloantigenic marker of lymphocyte differentiation. J Immunol (1980) 1.10
Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity. Immunity (1994) 1.10
Efficacy and safety of acarbose in insulin-treated patients with type 2 diabetes. Diabetes Care (1998) 1.09
Isoform-specific associations of CD45 with accessory molecules in human T lymphocytes. Eur J Immunol (1992) 1.09
Bias in the gamma delta T cell response to Listeria monocytogenes. V delta 6.3+ cells are a major component of the gamma delta T cell response to Listeria monocytogenes. J Immunol (1996) 1.09
Effector CD4 T cells are biochemically distinct from the memory subset: evidence for long-term persistence of effectors in vivo. J Immunol (1999) 1.08
Developmental control of lymphokine gene expression in fetal thymocytes during T-cell ontogeny. Proc Natl Acad Sci U S A (1989) 1.07
Regulated expression and structure of T cell receptor gamma/delta transcripts in human thymic ontogeny. EMBO J (1991) 1.07
Control of memory CD4 T cell activation: MHC class II molecules on APCs and CD4 ligation inhibit memory but not naive CD4 T cells. Immunity (1995) 1.06
An investigation into neurologic and neurobehavioral effects of long-term agrichemical use among deciduous fruit farm workers in the Western Cape, South Africa. Environ Res (1997) 1.06
Oral surgery: ARONJ masterclass. Br Dent J (2014) 1.06
Regulation of naive T cell differentiation by varying the potency of TCR signal transduction. Semin Immunol (1999) 1.05